FalconX, Jump, Galaxy Join $1B Solana Investment; Medical Device Firm Raises 58B Yen Amid Biotech Crypto Trend

Several leading institutions, including FalconX, Jump Trading, Galaxy Digital, Multicoin Capital, and Cantor Fitzgerald, are collaborating on a major investment initiative centered on Solana, a blockchain platform. This initiative involves a planned $1 billion deal to acquire and hold Solana's native token, $SOL, leveraging the largest quantity of SOL held on any public company's balance sheet. Concurrently, a U.S.-listed medical device company has announced a treasury strategy pivoting to Solana, securing over 58 billion yen (approximately $400 million) in funding, which has caused a notable spike in its stock price. This move is part of a broader trend in 2025 where at least ten biotech firms have shifted toward cryptocurrency-related strategies to boost their stock valuations, although these gains have often been short-lived. Meanwhile, SoftBank's shares have risen 61% in 2025, driven by investments in artificial intelligence and semiconductor sectors, positioning it as one of Tokyo's top-performing stocks this year.